ClearPoint Neuro, Inc. (CLPT)
USD 12.14
(-7.3%)
USD 12.14
(-7.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -20.98 Million USD | -34.74% |
| 2022 | -15.57 Million USD | -22.22% |
| 2021 | -12.74 Million USD | -166.35% |
| 2020 | -4.78 Million USD | -10.4% |
| 2019 | -4.33 Million USD | 15.65% |
| 2018 | -5.07 Million USD | 17.17% |
| 2017 | -6.17 Million USD | 12.74% |
| 2016 | -6.85 Million USD | 2.12% |
| 2015 | -6.97 Million USD | 7.56% |
| 2014 | -3.12 Million USD | -18.83% |
| 2013 | -6.16 Million USD | -111.45% |
| 2012 | -2.69 Million USD | 43.8% |
| 2011 | -5.45 Million USD | 25.33% |
| 2010 | -7.59 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.27 Million USD | -16.45% |
| 2024 Q1 | -3.75 Million USD | 12.47% |
| 2023 Q4 | -4.28 Million USD | 12.56% |
| 2023 Q1 | -5.44 Million USD | -26.07% |
| 2023 Q3 | -4.89 Million USD | 27.9% |
| 2023 Q2 | -6.79 Million USD | -24.83% |
| 2023 FY | - USD | -34.74% |
| 2022 Q3 | -3.79 Million USD | 4.58% |
| 2022 Q4 | -4.31 Million USD | -13.73% |
| 2022 Q1 | -3.63 Million USD | 7.74% |
| 2022 Q2 | -3.97 Million USD | -9.44% |
| 2022 FY | - USD | -22.22% |
| 2021 Q2 | -3.5 Million USD | -70.21% |
| 2021 FY | - USD | -166.35% |
| 2021 Q4 | -3.93 Million USD | -10.71% |
| 2021 Q1 | -2.05 Million USD | -92.37% |
| 2021 Q3 | -3.55 Million USD | -1.57% |
| 2020 Q2 | -1.46 Million USD | -26.35% |
| 2020 Q1 | -1.15 Million USD | 18.22% |
| 2020 Q4 | -1.06 Million USD | 11.15% |
| 2020 Q3 | -1.2 Million USD | 17.76% |
| 2020 FY | - USD | -10.4% |
| 2019 Q3 | -848.47 Thousand USD | 31.06% |
| 2019 Q4 | -1.41 Million USD | -66.99% |
| 2019 FY | - USD | 15.65% |
| 2019 Q1 | -906.35 Thousand USD | 7.51% |
| 2019 Q2 | -1.23 Million USD | -35.8% |
| 2018 Q2 | -1.61 Million USD | -13.27% |
| 2018 FY | - USD | 17.17% |
| 2018 Q4 | -979.94 Thousand USD | 18.52% |
| 2018 Q1 | -1.42 Million USD | 21.55% |
| 2018 Q3 | -1.2 Million USD | 25.75% |
| 2017 Q3 | -1.41 Million USD | 21.17% |
| 2017 FY | - USD | 12.74% |
| 2017 Q1 | -1.31 Million USD | 25.06% |
| 2017 Q2 | -1.79 Million USD | -36.59% |
| 2017 Q4 | -1.82 Million USD | -28.93% |
| 2016 Q3 | -1.71 Million USD | 14.57% |
| 2016 Q2 | -2 Million USD | -10.59% |
| 2016 Q1 | -1.81 Million USD | -32.13% |
| 2016 FY | - USD | 2.12% |
| 2016 Q4 | -1.75 Million USD | -2.27% |
| 2015 FY | - USD | 7.56% |
| 2015 Q4 | -1.37 Million USD | 26.33% |
| 2015 Q3 | -1.86 Million USD | 9.71% |
| 2015 Q2 | -2.06 Million USD | 28.65% |
| 2015 Q1 | -2.89 Million USD | -78.33% |
| 2014 Q3 | -2.52 Million USD | -20.47% |
| 2014 Q1 | -1.55 Million USD | 1.49% |
| 2014 Q4 | -1.62 Million USD | 35.83% |
| 2014 FY | - USD | -18.83% |
| 2014 Q2 | -2.09 Million USD | -34.51% |
| 2013 Q4 | -1.58 Million USD | 9.06% |
| 2013 FY | - USD | -111.45% |
| 2013 Q1 | -851.43 Thousand USD | -79.26% |
| 2013 Q2 | -1.22 Million USD | -44.46% |
| 2013 Q3 | -1.74 Million USD | -41.52% |
| 2012 Q4 | -474.96 Thousand USD | 48.01% |
| 2012 Q2 | 810.98 Thousand USD | 177.15% |
| 2012 Q1 | -1.05 Million USD | 19.83% |
| 2012 FY | - USD | 43.8% |
| 2012 Q3 | -913.61 Thousand USD | -212.66% |
| 2011 FY | - USD | 25.33% |
| 2011 Q3 | -925.44 Thousand USD | 37.06% |
| 2011 Q4 | -1.31 Million USD | -41.68% |
| 2011 Q2 | -1.47 Million USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -55.624% |
| Cerus Corporation | -26.53 Million USD | 20.904% |
| OrthoPediatrics Corp. | -8.38 Million USD | -150.436% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -100.0% |
| Talis Biomedical Corporation | -66.04 Million USD | 68.22% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -25.871% |
| Inogen, Inc. | -45.67 Million USD | 54.051% |
| Spectral AI, Inc. | -12.26 Million USD | -71.171% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 55.991% |
| CVRx, Inc. | -38.73 Million USD | 45.808% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -494.926% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -73.363% |
| Orthofix Medical Inc. | -86.98 Million USD | 75.871% |
| Venus Concept Inc. | -26.11 Million USD | 19.622% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 57.829% |
| Bioventus Inc. | -23.07 Million USD | 9.02% |
| BrainsWay Ltd. | -2.31 Million USD | -808.222% |
| Envoy Medical, Inc. | -18.23 Million USD | -15.084% |
| electroCore, Inc. | -17.76 Million USD | -18.181% |
| IceCure Medical Ltd | -15.25 Million USD | -37.606% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 57.812% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -24.522% |
| MaxCyte, Inc. | -44.12 Million USD | 52.436% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -78.539% |
| Nexalin Technology, Inc. | -5.69 Million USD | -268.743% |
| PAVmed Inc | -75.74 Million USD | 72.289% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 60.957% |
| RxSight, Inc. | -41.03 Million USD | 48.853% |
| Sight Sciences, Inc. | -49.41 Million USD | 57.525% |
| SI-BONE, Inc. | -34.44 Million USD | 39.067% |
| TELA Bio, Inc. | -40.63 Million USD | 48.345% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 63.997% |
| Treace Medical Concepts, Inc. | -39 Million USD | 46.193% |
| LivaNova PLC | 39.01 Million USD | 153.796% |
| 908 Devices Inc. | -34.02 Million USD | 38.313% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 81.021% |
| Nemaura Medical Inc. | -7.28 Million USD | -188.031% |
| NeuroPace, Inc. | -22.83 Million USD | 8.08% |
| LENSAR, Inc. | -8.71 Million USD | -140.865% |
| Apyx Medical Corporation | -18.11 Million USD | -15.884% |
| Cutera, Inc. | -136.56 Million USD | 84.63% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -520.976% |
| BioSig Technologies, Inc. | -28.15 Million USD | 25.441% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 934.221% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 105.472% |
| Axonics, Inc. | 7.77 Million USD | 369.955% |
| Outset Medical, Inc. | -153.78 Million USD | 86.352% |
| IRIDEX Corporation | -7.44 Million USD | -181.807% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 78.603% |
| IRadimed Corporation | 20.8 Million USD | 200.906% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -160.345% |
| INVO Bioscience, Inc. | -6.88 Million USD | -205.072% |
| Telesis Bio, Inc. | -40.49 Million USD | 48.166% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 157.227% |
| Varex Imaging Corporation | 67.2 Million USD | 131.234% |
| Quipt Home Medical Corp. | 44.07 Million USD | 147.625% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -93.091% |
| Pulmonx Corporation | -55.09 Million USD | 61.902% |
| Dynatronics Corporation | -976 Thousand USD | -2050.495% |
| Modular Medical, Inc. | -17.1 Million USD | -22.721% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -44.902% |
| Semler Scientific, Inc. | 23.58 Million USD | 188.978% |
| InMode Ltd. | 196.28 Million USD | 110.693% |
| Bruker Corporation | 599 Million USD | 103.504% |
| Cytosorbents Corporation | -28.81 Million USD | 27.149% |
| DexCom, Inc. | 916.7 Million USD | 102.29% |
| Align Technology, Inc. | 799.03 Million USD | 102.627% |
| Viveve Medical, Inc. | -20.61 Million USD | -1.804% |
| ZimVie Inc. | 91.07 Million USD | 123.046% |
| Movano Inc. | -29.12 Million USD | 27.935% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -376.157% |
| Nexalin Technology, Inc. | -5.69 Million USD | -268.743% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -494.926% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 89.217% |
| Profound Medical Corp. | -27.12 Million USD | 22.617% |
| Insulet Corporation | 323.6 Million USD | 106.486% |
| enVVeno Medical Corporation | -25.01 Million USD | 16.104% |
| Surmodics, Inc. | 1.18 Million USD | 1866.751% |
| iCAD, Inc. | -6.56 Million USD | -219.711% |
| Nuwellis, Inc. | -16.35 Million USD | -28.326% |
| Biotricity, Inc. | -8.82 Million USD | -137.748% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 78.331% |
| Aethlon Medical, Inc. | -11.84 Million USD | -77.136% |
| InspireMD, Inc. | -20.91 Million USD | -0.373% |
| PAVmed Inc. | -75.74 Million USD | 72.289% |
| BIOLASE, Inc. | -15.13 Million USD | -38.642% |
| Beyond Air, Inc. | -59.03 Million USD | 64.444% |
| FONAR Corporation | 28.25 Million USD | 174.293% |
| AxoGen, Inc. | -13.32 Million USD | -57.48% |
| Vivani Medical, Inc. | -26.6 Million USD | 21.118% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 185.526% |
| Inari Medical, Inc. | 7.11 Million USD | 395.079% |
| UFP Technologies, Inc. | 72.74 Million USD | 128.854% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -519.915% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -240.952% |
| Tenon Medical, Inc. | -15.52 Million USD | -35.169% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -37.489% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 49.395% |
| AdaptHealth Corp. | -171.09 Million USD | 87.732% |
| Sintx Technologies, Inc. | -6.6 Million USD | -218.015% |
| NanoVibronix, Inc. | -3.43 Million USD | -511.033% |
| Quanterix Corporation | -38.08 Million USD | 44.893% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -93.091% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 70063.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 92.43% |
| TransMedics Group, Inc. | -7.6 Million USD | -176.062% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 3.565% |
| NeuroMetrix, Inc. | -7.09 Million USD | -195.794% |
| Hyperfine, Inc. | -47.06 Million USD | 55.4% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 64.003% |
| Biomerica, Inc. | -5.99 Million USD | -250.225% |
| Bone Biologics Corporation | 479.57 Thousand USD | 4476.611% |
| AVITA Medical, Inc. | -39.56 Million USD | 46.954% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -128.815% |
| Silk Road Medical, Inc | -45.08 Million USD | 53.441% |